Allarity Therapeutics Inc

XNAS: ALLR

Download real time

0.93 -0.03 (-3.12%)

99.20% Fall from 52W High

960.1K XNAS Volume

XNAS 17 Mar, 2025 5:30 PM (EDT)

4.1

Market Cap

Low in industry

20.0

Beta 1Year

Very High Volatility

Insider Trading disclosures for Allarity Therapeutics Inc

The latest disclosure was made by Joseph W. Vazzano in Allarity Therapeutics Inc where a trade of 25,000 Stock Options done was reported to US exchanges on Jan. 22, 2025.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Security Type
Joseph W. Vazzano	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	22 Jan 2025	25,000	25,000	-		-	Stock Options
Thomas H. Jensen	CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	22 Jan 2025	396,734	396,734	-		0	Common Stock
Jeremy Graff	CDO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	22 Jan 2025	144,441	262,924	-		0	Common Stock
Laura E. Benjamin	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	22 Jan 2025	25,000	25,000	-		-	Stock Options
Alexander Epshinsky	CFO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	22 Jan 2025	29,496	85,051	-		0	Common Stock

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

View All The Insider Trades disclosures

Screeners based on Insider Trading and SAST parameters